Aquestive Therapeutics (AQST) Interest Coverage Ratio (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Interest Coverage Ratio of 0.57 for Q1 2026, up 74.51% year-over-year from 0.32 in Q1 2025, and up 97.01% quarter-over-quarter from 18.92 in Q4 2025.
Aquestive Therapeutics (AQST) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 0.57 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 74.51% year-over-year to 0.57; the TTM figure through Mar 2026 stood at 7.52 (down 59.34% YoY), while the FY2025 annual figure was 0.63, down 92.91% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.57, up from 18.92 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.01 in Q2 2024, with the low at 18.92 in Q4 2025.
- The 5-year median for Interest Coverage Ratio is 2.22 (2025), against an average of 3.34.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio soared 101.45% in 2024, then slumped 23879.54% in 2025.
- Aquestive Therapeutics' Interest Coverage Ratio stood at 6.98 in 2022, then fell by 4.09% to 7.27 in 2023, then jumped by 66.38% to 2.44 in 2024, then sank by 674.27% to 18.92 in 2025, then surged by 97.01% to 0.57 in 2026.
- Business Quant data shows AQST's Interest Coverage Ratio at 0.57 in Q1 2026, 18.92 in Q4 2025, and 3.86 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aquestive Therapeutics | 553.72 Mn | 553.72 Mn | 9.80 Mn | -2.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.51 |
| Mar 31, 2026 | -0.57 |
| Dec 31, 2025 | -18.92 |
| Sep 30, 2025 | -3.86 |
| Jun 30, 2025 | -1.35 |
| Mar 31, 2025 | -2.22 |
| Dec 31, 2024 | -2.44 |
| Sep 30, 2024 | -0.89 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | -0.91 |
| Dec 31, 2023 | -7.27 |
| Sep 30, 2023 | -0.52 |
| Jun 30, 2023 | -0.39 |
| Mar 31, 2023 | -0.42 |
| Dec 31, 2022 | -6.98 |
| Sep 30, 2022 | -3.14 |
| Jun 30, 2022 | -4.05 |
| Mar 31, 2022 | -2.81 |
| Dec 31, 2021 | -6.69 |
| Sep 30, 2021 | -1.94 |